Research Topics
| Judith BaarsSummaryPublications: Baars JE, Kuipers EJ, van Dekken J, van der Woude CJ. Surgery is indicated for persistent enterocutaneous fistulizing Crohn?s disease. Clinical Medicine: Gastroenterology 2008;1:1-3 Baars JE, Siegel CA, Kuipers EJ, van der Woude CJ. Patient?s perspectives important for early anti-TNF treatment in inflammatory bowel Disease. Digestion 2009;79:30-35 Baars JE, Zelinkova Z, Mensink PBF, Markus T, Looman CWN, Kuipers EJ, van der Woude CJ. High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients? organization: a patient empowerment study. Aliment Pharmacol Ther 2009;30:864-872 Baars JE, Markus T, Kuipers EJ, van der Woude CJ. Patients? Preferences regarding Shared Decision-Making in the Treatment of Inflammatory Bowel Disease: Results from a Patient-Empowerment Study. Digestion 2010;81:113-119 Siegel CA, Schwartz LM, Woloshin S, Cole EB, Rubin DT, Vay T, Baars JE, Sands BE. When Should Ulcerative Colitis Patients Undergo Colectomy for Dysplasia? Mismatch Between Patient Preferences and Physician Recommendations. Inflamm Bowel Dis. 2010; 16:1658-62. Baars JE, Siegel CA, van ?t Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Digestive and liver disease 2010; 42(11):777-84 Baars JE, Vogelaar L, Wolfhagen FHW, Biermann K, Kuipers EJ, van der Woude CJ. A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial. Journal of Crohn?s and Colitis 2010; 4(6):661-8. Baars JE, Looman CWN, Steyerberg EW, Kuipers EJ, van der Woude CJ. Individualized surveillance strategies for colorectal cancer in inflammatory bowel disease, GUT 2010; Dec 13 [Epub ahead of print] Baars JE, Looman CWN, Steyerberg EW, Beukers R, Tan ACITL, Weusten BLAM, Kuipers EJ, van der Woude CJ. The risk of inflammatory bowel disease related colorectal carcinoma is limited: results from a nationwide nested case-control study. American Journal of Gastroenterology 2011; 106(2):319-28 Baars JE, Kuipers EJ, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PCF, Oldenburg B, Pierik M, Wahab PJ, van Bodegraven AA, van der Woude CJ, and the initiative for Crohn and Colitis. Malignant transformation of perianal- and enterocutaneous fistulas occurs rarely: Results of 17 years of follow-up from The Netherlands. Scand J Gastroenterol. 201146 (3):319-25. Publications
|
Detail Information
Publications
High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment studyJ E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
Aliment Pharmacol Ther 30:864-72. 2009..Adherence is important for successful treatment in inflammatory bowel disease (IBD) patients. Previous studies demonstrated high prevalence of non-adherence...
Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancerJudith E Baars
Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, Postbus 2040, 3000 CA Rotterdam, The Netherlands
Dig Liver Dis 42:777-84. 2010..We assessed patients' knowledge of disease and its associated risks/complications, and their perspectives on current recommendations for colectomy when low-grade dysplasia is found...
Patients' preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment studyJudith E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands j baars erasmusmc nl
Digestion 81:113-9. 2010..Because data are lacking on the preferences of patients with chronic diseases such as inflammatory bowel disease (IBD), we wanted to assess IBD patients' preferences about being involved in such decisions...
When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendationsCorey A Siegel
Dartmouth Hitchcock Inflammatory Bowel Disease Center, Lebanon, New Hampshire, USA
Inflamm Bowel Dis 16:1658-62. 2010..The objective was to learn if UC patients' perceptions of their colon cancer risk and if their preferences for elective colectomy match with physicians' recommendations if dysplasia was found...
A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trialJudith E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
J Crohns Colitis 4:661-8. 2010..This randomized controlled trial assessed the effectiveness of a low dose of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation...
Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term surveyJ E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, s Gravendijkwal 230, Room Ba 393, 3015 CE Rotterdam, The Netherlands
J Gastroenterol 47:1308-22. 2012..We studied patient and disease characteristics of IBD-related CRC in a nationwide IBD cohort in general hospitals. Main outcome parameters were time to develop CRC, and factors associated with early CRC development...
Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammationJudith E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
Inflamm Bowel Dis 18:1634-40. 2012..Management of inflammatory bowel disease (IBD) is increasingly focused on mucosal remission. We assessed the prevalence of mucosal inflammation during clinical remission, the clinical consequences, and the impact on disease course...
Small bowel carcinoma mimicking a relapse of Crohn's disease: a case seriesJ E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
J Crohns Colitis 5:152-6. 2011..This case series underlines the necessity of performing a full work up in the diagnosis of CD and to consider small bowel carcinoma in patients with small bowel CD failing medical therapy...
Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The NetherlandsJudith E Baars
Department of Gastroenterology and Hepatology, Erasmus Medical Center, Gravendijkwal 230, Rotterdam, The Netherlands
Scand J Gastroenterol 46:319-25. 2011..We investigated adenocarcinoma originating from perianal and enterocutaneous fistulas in both CD patients and non-CD patients from nine large, mostly tertiary referral, hospitals in The Netherlands...
The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control studyJudith E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
Am J Gastroenterol 106:319-28. 2011..We performed a nationwide nested case-control study to assess the risk for IBD-related CRC and associated prognostic factors in general hospitals...
Patient's perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel diseaseJudith E Baars
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
Digestion 79:30-5. 2009..We assessed the perspectives of patients with inflammatory bowel disease (IBD) concerning the treatment-associated risks/benefits of infliximab...
